$IDIX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDENIX PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IDENIX PHARMACEUTICALS INC. Get notifications about new insider transactions in IDENIX PHARMACEUTICALS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12 2014 | IDIX | IDENIX PHARMACEUTI ... | NOVARTIS PHARMA AG | 10% Owner | Sell | U | 24.50 | 33,320,674 | 816,356,513 | 0 | 33.3 M to 0 (-100.00 %) |
| Aug 12 2014 | IDIX | IDENIX PHARMACEUTI ... | BAUPOST GROUP LLC/MA | 10% Owner | Sell | J | 24.50 | 53,331,109 | 1,306,612,171 | 0 | 53.3 M to 0 (-100.00 %) |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | WYZGA MICHAEL S | Director | Option Exercise | D | 6.88 | 20,000 | 137,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | WYZGA MICHAEL S | Director | Option Exercise | D | 4.94 | 20,000 | 98,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | WYZGA MICHAEL S | Director | Option Exercise | D | 9.03 | 20,000 | 180,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | WYZGA MICHAEL S | Director | Option Exercise | D | 11.93 | 5,000 | 59,650 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | WYZGA MICHAEL S | Director | Option Exercise | D | 11.93 | 15,000 | 178,950 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Rowland Charles A Jr | Director | Option Exercise | D | 6.88 | 20,000 | 137,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Rowland Charles A Jr | Director | Option Exercise | D | 4.94 | 20,000 | 98,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Rowland Charles A Jr | Director | Option Exercise | D | 4.94 | 20,000 | 98,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Pollard-Knight Denise | Director | Option Exercise | D | 6.88 | 20,000 | 137,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Pollard-Knight Denise | Director | Option Exercise | D | 4.94 | 20,000 | 98,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Pollard-Knight Denise | Director | Option Exercise | D | 9.03 | 20,000 | 180,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Pollard-Knight Denise | Director | Option Exercise | D | 4.57 | 20,000 | 91,400 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Pollard-Knight Denise | Director | Option Exercise | D | 4.09 | 20,000 | 81,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Pollard-Knight Denise | Director | Option Exercise | D | 3.49 | 20,000 | 69,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Pollard-Knight Denise | Director | Option Exercise | D | 6.71 | 20,000 | 134,200 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Pollard-Knight Denise | Director | Option Exercise | D | 7.33 | 20,000 | 146,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Pollard-Knight Denise | Director | Option Exercise | D | 8.85 | 20,000 | 177,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOWSON TAMAR D | Director | Option Exercise | D | 6.88 | 20,000 | 137,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOWSON TAMAR D | Director | Option Exercise | D | 4.94 | 20,000 | 98,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOWSON TAMAR D | Director | Option Exercise | D | 9.03 | 20,000 | 180,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOWSON TAMAR D | Director | Option Exercise | D | 4.57 | 20,000 | 91,400 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOWSON TAMAR D | Director | Option Exercise | D | 4.09 | 20,000 | 81,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOWSON TAMAR D | Director | Option Exercise | D | 2.79 | 3,333 | 9,299 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOWSON TAMAR D | Director | Option Exercise | D | 2.79 | 15,000 | 41,850 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HODGSON THOMAS R | Director | Option Exercise | D | 6.88 | 20,000 | 137,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HODGSON THOMAS R | Director | Option Exercise | D | 4.94 | 20,000 | 98,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HODGSON THOMAS R | Director | Option Exercise | D | 9.03 | 20,000 | 180,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HODGSON THOMAS R | Director | Option Exercise | D | 4.57 | 20,000 | 91,400 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HODGSON THOMAS R | Director | Option Exercise | D | 4.09 | 20,000 | 81,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HODGSON THOMAS R | Director | Option Exercise | D | 3.49 | 20,000 | 69,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HODGSON THOMAS R | Director | Option Exercise | D | 6.71 | 20,000 | 134,200 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HODGSON THOMAS R | Director | Option Exercise | D | 7.33 | 20,000 | 146,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HODGSON THOMAS R | Director | Option Exercise | D | 8.85 | 20,000 | 177,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HODGSON THOMAS R | Director | Option Exercise | D | 18.88 | 20,000 | 377,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOCKMEYER WAYNE T | Director | Option Exercise | D | 6.88 | 20,000 | 137,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOCKMEYER WAYNE T | Director | Option Exercise | D | 4.94 | 20,000 | 98,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOCKMEYER WAYNE T | Director | Option Exercise | D | 9.03 | 20,000 | 180,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOCKMEYER WAYNE T | Director | Option Exercise | D | 4.57 | 20,000 | 91,400 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOCKMEYER WAYNE T | Director | Option Exercise | D | 4.09 | 20,000 | 81,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOCKMEYER WAYNE T | Director | Option Exercise | D | 3.49 | 20,000 | 69,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOCKMEYER WAYNE T | Director | Option Exercise | D | 6.71 | 20,000 | 134,200 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOCKMEYER WAYNE T | Director | Option Exercise | D | 7.33 | 20,000 | 146,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOCKMEYER WAYNE T | Director | Option Exercise | D | 8.85 | 20,000 | 177,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | HOCKMEYER WAYNE T | Director | Option Exercise | D | 18.88 | 20,000 | 377,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Stahl Maria D | SVP & General Couns ... | Option Exercise | D | 7.01 | 100,000 | 701,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Stahl Maria D | SVP & General Couns ... | Option Exercise | D | 4.65 | 100,000 | 465,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Stahl Maria D | SVP & General Couns ... | Option Exercise | D | 12.08 | 100,000 | 1,208,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Stahl Maria D | SVP & General Couns ... | Option Exercise | D | 3.17 | 80,000 | 253,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Stahl Maria D | SVP & General Couns ... | Option Exercise | D | 3.87 | 150,000 | 580,500 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Option Exercise | D | 7.23 | 400,000 | 2,892,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Option Exercise | D | 4.61 | 500,000 | 2,305,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Option Exercise | D | 11.93 | 375,000 | 4,473,750 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Option Exercise | D | 3.14 | 300,000 | 942,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Option Exercise | D | 4.28 | 300,000 | 1,284,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Option Exercise | D | 2.96 | 65,000 | 192,400 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Option Exercise | D | 5.46 | 110,000 | 600,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Option Exercise | D | 5.18 | 80,000 | 414,400 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Option Exercise | D | 2.41 | 10 | 24 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Option Exercise | D | 6.12 | 225,000 | 1,377,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Mayers Douglas L | EVP and Chief Medic ... | Option Exercise | D | 7.01 | 100,000 | 701,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Mayers Douglas L | EVP and Chief Medic ... | Option Exercise | D | 4.65 | 120,000 | 558,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Mayers Douglas L | EVP and Chief Medic ... | Option Exercise | D | 12.08 | 125,000 | 1,510,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Mayers Douglas L | EVP and Chief Medic ... | Option Exercise | D | 3.17 | 60,000 | 190,200 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Mayers Douglas L | EVP and Chief Medic ... | Option Exercise | D | 2.96 | 40,000 | 118,400 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Mayers Douglas L | EVP and Chief Medic ... | Option Exercise | D | 5.46 | 40,000 | 218,400 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Mayers Douglas L | EVP and Chief Medic ... | Option Exercise | D | 5.18 | 80,000 | 414,400 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Mayers Douglas L | EVP and Chief Medic ... | Option Exercise | D | 2.41 | 40,000 | 96,400 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Mayers Douglas L | EVP and Chief Medic ... | Option Exercise | D | 8.88 | 100,000 | 888,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Option Exercise | D | 7.01 | 80,000 | 560,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Option Exercise | D | 4.65 | 60,000 | 279,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Option Exercise | D | 12.08 | 60,000 | 724,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Option Exercise | D | 3.17 | 40,000 | 126,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Option Exercise | D | 2.96 | 35,000 | 103,600 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Option Exercise | D | 5.46 | 30,000 | 163,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Option Exercise | D | 5.18 | 40,000 | 207,200 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Option Exercise | D | 8.12 | 15,000 | 121,800 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Option Exercise | D | 21.11 | 15,000 | 316,650 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Option Exercise | D | 19.14 | 15,000 | 287,100 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Dumas Jacques | EVP, Chief Scientif ... | Option Exercise | D | 7.42 | 250,000 | 1,855,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Beckman Daniella | SVP, CFO and Treasu ... | Option Exercise | D | 7.01 | 100,000 | 701,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Beckman Daniella | SVP, CFO and Treasu ... | Option Exercise | D | 4.65 | 100,000 | 465,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Beckman Daniella | SVP, CFO and Treasu ... | Option Exercise | D | 12.08 | 100,000 | 1,208,000 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Beckman Daniella | SVP, CFO and Treasu ... | Option Exercise | D | 4.57 | 50,000 | 228,500 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Beckman Daniella | SVP, CFO and Treasu ... | Option Exercise | D | 3.17 | 30,000 | 95,100 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Beckman Daniella | SVP, CFO and Treasu ... | Option Exercise | D | 2.96 | 7,500 | 22,200 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Beckman Daniella | SVP, CFO and Treasu ... | Option Exercise | D | 5.46 | 6,000 | 32,760 | 0 | |
| Aug 05 2014 | IDIX | IDENIX PHARMACEUTI ... | Beckman Daniella | SVP, CFO and Treasu ... | Option Exercise | D | 5.32 | 15,000 | 79,800 | 0 | |
| Jul 11 2014 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Buy | J | 0.00 | 89,990 | 0 | 89,990 | 0 to 90 K |
| Jul 11 2014 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Gift | G | 0.00 | 89,990 | 0 | 0 | 90 K to 0 (-100.00 %) |
| Jun 06 2014 | IDIX | IDENIX PHARMACEUTI ... | WYZGA MICHAEL S | Director | Option Exercise | A | 6.88 | 20,000 | 137,600 | 20,000 | |
| Jun 06 2014 | IDIX | IDENIX PHARMACEUTI ... | Rowland Charles A Jr | Director | Option Exercise | A | 6.88 | 20,000 | 137,600 | 20,000 | |
| Jun 06 2014 | IDIX | IDENIX PHARMACEUTI ... | Pollard-Knight Denise | Director | Option Exercise | A | 6.88 | 20,000 | 137,600 | 20,000 | |
| Jun 06 2014 | IDIX | IDENIX PHARMACEUTI ... | HODGSON THOMAS R | Director | Option Exercise | A | 6.88 | 20,000 | 137,600 | 20,000 | |
| Jun 06 2014 | IDIX | IDENIX PHARMACEUTI ... | HOWSON TAMAR D | Director | Option Exercise | A | 6.88 | 20,000 | 137,600 | 20,000 | |
| Jun 06 2014 | IDIX | IDENIX PHARMACEUTI ... | HOCKMEYER WAYNE T | Director | Option Exercise | A | 6.88 | 20,000 | 137,600 | 20,000 | |
| Feb 12 2014 | IDIX | IDENIX PHARMACEUTI ... | Stahl Maria D | SVP & General Couns ... | Option Exercise | A | 7.01 | 100,000 | 701,000 | 100,000 | |
| Feb 12 2014 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Option Exercise | A | 7.23 | 400,000 | 2,892,000 | 400,000 | |
| Feb 12 2014 | IDIX | IDENIX PHARMACEUTI ... | Mayers Douglas L | EVP and Chief Medic ... | Option Exercise | A | 7.01 | 100,000 | 701,000 | 100,000 | |
| Feb 12 2014 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Option Exercise | A | 7.01 | 80,000 | 560,800 | 80,000 | |
| Feb 12 2014 | IDIX | IDENIX PHARMACEUTI ... | Beckman Daniella | SVP, CFO and Treasu ... | Option Exercise | A | 7.01 | 100,000 | 701,000 | 100,000 | |
| Feb 04 2014 | IDIX | IDENIX PHARMACEUTI ... | BAUPOST GROUP LLC/MA | 10% Owner | Buy | P | 6.50 | 16,420,241 | 106,731,567 | 53,331,109 | 36.9 M to 53.3 M (+44.49 %) |
| Jun 10 2013 | IDIX | IDENIX PHARMACEUTI ... | Rowland Charles A Jr | Director | Option Exercise | A | 4.94 | 20,000 | 98,800 | 20,000 | |
| Jun 10 2013 | IDIX | IDENIX PHARMACEUTI ... | Rowland Charles A Jr | Director | Option Exercise | A | 4.94 | 20,000 | 98,800 | 20,000 | |
| Jun 10 2013 | IDIX | IDENIX PHARMACEUTI ... | WYZGA MICHAEL S | Director | Option Exercise | A | 4.94 | 20,000 | 98,800 | 20,000 | |
| Jun 10 2013 | IDIX | IDENIX PHARMACEUTI ... | Pollard-Knight Denise | Director | Option Exercise | A | 4.94 | 20,000 | 98,800 | 20,000 | |
| Jun 10 2013 | IDIX | IDENIX PHARMACEUTI ... | HOWSON TAMAR D | Director | Option Exercise | A | 4.94 | 20,000 | 98,800 | 20,000 | |
| Jun 10 2013 | IDIX | IDENIX PHARMACEUTI ... | HODGSON THOMAS R | Director | Option Exercise | A | 4.94 | 20,000 | 98,800 | 20,000 | |
| Jun 10 2013 | IDIX | IDENIX PHARMACEUTI ... | HOCKMEYER WAYNE T | Director | Option Exercise | A | 4.94 | 20,000 | 98,800 | 20,000 | |
| Feb 22 2013 | IDIX | IDENIX PHARMACEUTI ... | Standring David | EVP & Chief Scienti ... | Option Exercise | A | 4.65 | 95,000 | 441,750 | 95,000 | |
| Feb 22 2013 | IDIX | IDENIX PHARMACEUTI ... | Stahl Maria D | SVP & General Couns ... | Option Exercise | A | 4.65 | 100,000 | 465,000 | 100,000 | |
| Feb 22 2013 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Option Exercise | A | 4.61 | 500,000 | 2,305,000 | 500,000 | |
| Feb 22 2013 | IDIX | IDENIX PHARMACEUTI ... | Mayers Douglas L | EVP and Chief Medic ... | Option Exercise | A | 4.65 | 120,000 | 558,000 | 120,000 | |
| Feb 22 2013 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Option Exercise | A | 4.65 | 60,000 | 279,000 | 60,000 | |
| Feb 22 2013 | IDIX | IDENIX PHARMACEUTI ... | Beckman Daniella | SVP, CFO and Treasu ... | Option Exercise | A | 4.65 | 100,000 | 465,000 | 100,000 | |
| Dec 17 2012 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Option Exercise | M | 2.96 | 35,000 | 103,600 | 65,000 | |
| Dec 17 2012 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Option Exercise | M | 2.41 | 39,990 | 96,376 | 10 | |
| Dec 17 2012 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Buy | M | 2.96 | 35,000 | 103,600 | 89,990 | 55 K to 90 K (+63.65 %) |
| Dec 17 2012 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Buy | M | 2.41 | 39,990 | 96,376 | 54,990 | 15 K to 55 K (+266.60 %) |
| Jun 11 2012 | IDIX | IDENIX PHARMACEUTI ... | WYZGA MICHAEL S | Director | Option Exercise | A | 9.03 | 20,000 | 180,600 | 20,000 | |
| Jun 11 2012 | IDIX | IDENIX PHARMACEUTI ... | Pollard-Knight Denise | Director | Option Exercise | A | 9.03 | 20,000 | 180,600 | 20,000 | |
| Jun 11 2012 | IDIX | IDENIX PHARMACEUTI ... | HOCKMEYER WAYNE T | Director | Option Exercise | A | 9.03 | 20,000 | 180,600 | 20,000 | |
| Jun 11 2012 | IDIX | IDENIX PHARMACEUTI ... | HOWSON TAMAR D | Director | Option Exercise | A | 9.03 | 20,000 | 180,600 | 20,000 | |
| Jun 11 2012 | IDIX | IDENIX PHARMACEUTI ... | HODGSON THOMAS R | Director | Option Exercise | A | 9.03 | 20,000 | 180,600 | 20,000 | |
| Mar 20 2012 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Option Exercise | M | 2.41 | 30,000 | 72,300 | 0 | |
| Mar 20 2012 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Sell | S | 11.04 | 30,000 | 331,200 | 1,300 | 31.3 K to 1.3 K (-95.85 %) |
| Mar 20 2012 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Buy | M | 2.41 | 30,000 | 72,300 | 31,300 | 1.3 K to 31.3 K (+2,307.69 %) |
| Mar 02 2012 | IDIX | IDENIX PHARMACEUTI ... | Standring David | EVP & Chief Scienti ... | Option Exercise | A | 12.08 | 125,000 | 1,510,000 | 125,000 | |
| Mar 02 2012 | IDIX | IDENIX PHARMACEUTI ... | Stahl Maria D | SVP & General Couns ... | Option Exercise | A | 12.08 | 100,000 | 1,208,000 | 100,000 | |
| Mar 02 2012 | IDIX | IDENIX PHARMACEUTI ... | Mayers Douglas L | EVP and Chief Medic ... | Option Exercise | A | 12.08 | 125,000 | 1,510,000 | 125,000 | |
| Mar 02 2012 | IDIX | IDENIX PHARMACEUTI ... | Fanning Paul | SVP, Human Resource ... | Option Exercise | A | 12.08 | 60,000 | 724,800 | 60,000 | |
| Mar 02 2012 | IDIX | IDENIX PHARMACEUTI ... | Beckman Daniella | SVP, CFO and Treasu ... | Option Exercise | A | 12.08 | 100,000 | 1,208,000 | 100,000 | |
| Mar 02 2012 | IDIX | IDENIX PHARMACEUTI ... | Renaud Ronald C JR | President & CEO | Option Exercise | A | 11.93 | 375,000 | 4,473,750 | 375,000 | |
| Mar 02 2012 | IDIX | IDENIX PHARMACEUTI ... | WYZGA MICHAEL S | Director | Option Exercise | A | 11.93 | 5,000 | 59,650 | 5,000 | |
| Mar 02 2012 | IDIX | IDENIX PHARMACEUTI ... | WYZGA MICHAEL S | Director | Option Exercise | A | 11.93 | 15,000 | 178,950 | 15,000 | |
| Feb 23 2012 | IDIX | IDENIX PHARMACEUTI ... | NOVARTIS AG | Buy | P | 7.39 | 2,133 | 15,763 | 33,320,674 | 33.3 M to 33.3 M (+0.01 %) | |
| Feb 23 2012 | IDIX | IDENIX PHARMACEUTI ... | NOVARTIS AG | Buy | P | 6.52 | 493 | 3,214 | 33,318,541 | 33.3 M to 33.3 M (0.00 %) | |
| Feb 23 2012 | IDIX | IDENIX PHARMACEUTI ... | NOVARTIS AG | Buy | P | 5.80 | 436 | 2,529 | 33,318,048 | 33.3 M to 33.3 M (0.00 %) | |
| Feb 23 2012 | IDIX | IDENIX PHARMACEUTI ... | NOVARTIS AG | Buy | P | 5.79 | 883 | 5,113 | 33,317,612 | 33.3 M to 33.3 M (0.00 %) | |
| Feb 23 2012 | IDIX | IDENIX PHARMACEUTI ... | NOVARTIS AG | Buy | P | 5.46 | 7,402 | 40,415 | 33,316,729 | 33.3 M to 33.3 M (+0.02 %) | |
| Feb 23 2012 | IDIX | IDENIX PHARMACEUTI ... | NOVARTIS AG | Buy | P | 5.11 | 11,433 | 58,423 | 33,309,327 | 33.3 M to 33.3 M (+0.03 %) | |
| Feb 23 2012 | IDIX | IDENIX PHARMACEUTI ... | NOVARTIS AG | Buy | P | 5.10 | 39 | 199 | 33,297,894 | 33.3 M to 33.3 M (0.00 %) | |
| Feb 23 2012 | IDIX | IDENIX PHARMACEUTI ... | NOVARTIS AG | Buy | P | 3.79 | 3,093 | 11,722 | 33,297,855 | 33.3 M to 33.3 M (+0.01 %) | |
| Feb 23 2012 | IDIX | IDENIX PHARMACEUTI ... | NOVARTIS AG | Buy | P | 3.17 | 4,336 | 13,745 | 33,294,762 | 33.3 M to 33.3 M (+0.01 %) | |
| Feb 23 2012 | IDIX | IDENIX PHARMACEUTI ... | NOVARTIS AG | Buy | P | 3.04 | 232 | 705 | 33,290,426 | 33.3 M to 33.3 M (0.00 %) | |
| Feb 23 2012 | IDIX | IDENIX PHARMACEUTI ... | NOVARTIS AG | Buy | P | 2.97 | 427 | 1,268 | 33,290,194 | 33.3 M to 33.3 M (0.00 %) | |
| Feb 23 2012 | IDIX | IDENIX PHARMACEUTI ... | NOVARTIS AG | Buy | P | 2.96 | 8,960 | 26,522 | 33,289,767 | 33.3 M to 33.3 M (+0.03 %) | |
| Feb 23 2012 | IDIX | IDENIX PHARMACEUTI ... | NOVARTIS AG | Buy | P | 2.90 | 3,117 | 9,039 | 33,280,807 | 33.3 M to 33.3 M (+0.01 %) | |
| Feb 23 2012 | IDIX | IDENIX PHARMACEUTI ... | NOVARTIS AG | Buy | P | 2.85 | 1,321 | 3,765 | 33,277,690 | 33.3 M to 33.3 M (0.00 %) |